COVID-19 Infection-Related Coagulopathy and Viscoelastic Methods: A Paradigm for Their Clinical Utility in Critical Illness
暂无分享,去创建一个
S. Bonovas | F. Frantzeskaki | A. G. Tsantes | A. Tsantes | I. Tsangaris | S. Kokoris | P. Kopterides | A. Tsantes | Styliani Kokoris
[1] J. van der Linden,et al. Rotational thromboelastometry results are associated with care level in COVID-19 , 2020, Journal of Thrombosis and Thrombolysis.
[2] M. Bruegel,et al. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients , 2020, Thrombosis Research.
[3] T. Lisman,et al. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation , 2020, Journal of Thrombosis and Haemostasis.
[4] C. Kempton,et al. Fibrinolysis Shutdown and Thrombosis in A COVID-19 ICU. , 2020, Shock.
[5] P. Navalesi,et al. Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit , 2020, Thrombosis and Haemostasis.
[6] Luke W Collett,et al. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study , 2020, Australian Critical Care.
[7] C. Ferrando,et al. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there? , 2020, Journal of Thrombosis and Thrombolysis.
[8] L. Argaud,et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis , 2020, Journal of Thrombosis and Haemostasis.
[9] M. Bottai,et al. Rotational Thromboelastometry predicts care level in Covid-19 , 2020, medRxiv.
[10] B. Trautner,et al. Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill , 2020, JAMA network open.
[11] V. Schini-Kerth,et al. COVID-19 Related Coagulopathy: A Distinct Entity? , 2020, Journal of clinical medicine.
[12] J. Thachil,et al. Coagulopathy of Coronavirus Disease 2019 , 2020, Critical care medicine.
[13] S. Bonovas,et al. ROTEM diagnostic capacity for measuring fibrinolysis in neonatal sepsis. , 2020, Thrombosis research.
[14] V. Siguret,et al. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19 , 2020, Intensive Care Medicine.
[15] R. McIntyre,et al. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection , 2020, Journal of the American College of Surgeons.
[16] Mickaël Ohana,et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.
[17] F. Frigieri,et al. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia , 2020, Journal of Thrombosis and Thrombolysis.
[18] P. Navalesi,et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure , 2020, Thrombosis and Haemostasis.
[19] L. Menicanti,et al. The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome , 2020, Journal of Thrombosis and Haemostasis.
[20] G. Grasselli,et al. Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis , 2020, Journal of Thrombosis and Haemostasis.
[21] A. Zangrillo,et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis , 2020, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[22] G. Danzi,et al. Acute pulmonary embolism and COVID-19 pneumonia: a random association? , 2020, European heart journal.
[23] A. Falanga,et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.
[24] M. Maegele,et al. The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management , 2019, Korean journal of anesthesiology.
[25] S. Bonovas,et al. Thromboelastometry for diagnosis of neonatal sepsis-associated coagulopathy: an observational study , 2018, European Journal of Pediatrics.
[26] C. Longstaff. Measuring fibrinolysis: from research to routine diagnostic assays , 2018, Journal of thrombosis and haemostasis : JTH.
[27] A. Sauaia,et al. Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients. , 2016, Journal of the American College of Surgeons.
[28] D. Consonni,et al. Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography , 2015, PloS one.
[29] N. Mackman,et al. Multiple roles of the coagulation protease cascade during virus infection. , 2014, Blood.
[30] N. Juffermans,et al. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review , 2014, Critical Care.
[31] Bobbie-Jo M. Webb-Robertson,et al. Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury , 2013, mBio.
[32] A. Perner,et al. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study. , 2013, Journal of critical care.
[33] S. Stanworth,et al. The incidence and magnitude of fibrinolytic activation in trauma patients , 2013, Journal of thrombosis and haemostasis : JTH.
[34] S. Revel-Vilk. The conundrum of neonatal coagulopathy. , 2012, Hematology. American Society of Hematology. Education Program.
[35] A. Mehrabi,et al. Viscoelastic and aggregometric point‐of‐care testing in patients with septic shock – cross‐links between inflammation and haemostasis , 2012, Acta anaesthesiologica Scandinavica.
[36] H. Eggebrecht,et al. Comparison of Thrombelastometry with Simplified Acute Physiology Score II and Sequential Organ Failure Assessment Scores for the Prediction of 30-Day Survival: A Cohort Study , 2011, Shock.
[37] H. Eggebrecht,et al. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults , 2010, Critical care.
[38] V. Pettilä,et al. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation , 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[39] J. Takala,et al. Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study , 2009, Critical care.
[40] K. Inaba,et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. , 2008, British journal of anaesthesia.
[41] T. van der Poll,et al. Sepsis and Disseminated Intravascular Coagulation , 2003, Journal of Thrombosis and Thrombolysis.
[42] G. Hadley,et al. Prediction of neonatal sepsis by thromboelastography , 1997, Pediatric Surgery International.
[43] M. Levi,et al. DIC: which laboratory tests are most useful. , 2011, Blood reviews.
[44] 江口 和夫,et al. 肝・胆道疾患の Thrombelastography , 1977 .